SHTDY vs IBP
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
SHTDY · SINOPHARM GROUP CO$10.96 ▲ 2.24%
IBP · Installed Building Products$220.06 ▼ 1.35%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- SHTDY -11.1%
- IBP -13.4%
Head to head
| Metric | SHTDY | IBP |
|---|---|---|
| Price | $10.96 | $220.06 |
| Change today | ▲ 2.24% | ▼ 1.35% |
| Market cap | $5.84B | $5.85B |
| Return, 3 months | +1.0% | -6.5% |
| Return, year to date | -7.1% | -14.1% |
| Return, 1 year | -10.0% | -13.5% |
| P/E (TTM) | 6.8 | 25.1 |
| P/B | 0.5 | 8.4 |
| P/E percentile vs own 5y | – | 56th |
| Dividend yield | 4.59% | 1.52% |
| Revenue growth (YoY, latest qtr) | – | +2.3% |
| Net profit growth (YoY) | – | -5.9% |
| Gross margin | – | 33.6% |
| Operating margin | – | 12.4% |
| Net margin | – | 8.5% |
| Return on equity | – | 38.5% |
| Analyst target vs. price | – | +1.9% |
| Analyst buy share | – | 33% |
| RSI (14) | 73 | 58 |
| 30-day volatility | 24.2% | 53.4% |
| Max drawdown, 1 year | -30.2% | -47.0% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- IBP is the largest of the group by market value.
- SHTDY has returned the most over the past year.
- SHTDY carries the lowest trailing P/E.
- SHTDY pays the highest dividend yield.
- SHTDY has been the calmest stock over the last 30 days.